C3.ai, Inc. operates as an enterprise artificial intelligence application software company in North America, Europe, the Middle East, Africa, the Asia Pacific, and internationally. It offers C3 agentic AI platform, an application development and runtime environment that enables customers to design, develop, and deploy enterprise AI applications; C3 AI Studio, an integrated development environment in the C3 Agentic AI Platform that enables engineers, data scientists, and business analysts to design, build, test, and deploy AI applications; C3 AI Applications, a portfolio of industry-specific enterprise AI applications that enables the digital transformation of organizations globally; and C3 Generative AI, a library of agentic AI applications to retrieve data, analyze information, surface insights, and orchestrate workflows. The company also provides C3 Code, a solution that enables users to build, configure, and deploy a complete and production-grade Enterprise AI applications automatically, including data pipelines, AI models, business logic, security controls, and user interfaces. It has strategic partnerships with Microsoft, AWS, Google Cloud, McKinsey & Company, and Baker Hughes. The company was formerly known as C3 IoT, Inc. and changed its name to C3.ai, Inc. in June 2019. C3.ai, Inc. was incorporated in 2009 and is headquartered in Redwood City, California.…
C3.ai (AI) Is Getting Fresh Attention, What Are Investors Weighing?
C3.ai (NYSE: AI) is listed on the New York Stock Exchange, where its shares trade in USD. It belongs to the Software - Infrastructure industry, part of the Technology sector, and reports about 764 employees.
The shares were at 9.130 USD on 20 November 2026, down 41.2% over 52 weeks. Its 52-week range is 7.675 USD to 17.45 USD: the price is 47.7% below the high and 19.0% above the low.
Its market capitalisation is 1.47B USD.
C3.ai reports return on equity of -71.9%, an operating margin of -198.1% and revenue down 25.5% year over year.
It holds more cash than debt, a net cash position of 591.60M USD. Its Piotroski F-score is 1 out of 9, a weak reading of its financial health. 10 analysts cover the stock, with an average rating of Underperform; their mean price target of 8.900 USD is 2.5% below the current price. The next earnings report is expected on 9 December 2026.